Tumor Clinical Trial
Official title:
The Needs and Burden of Family Caregivers of Older Adults With Cancer and Their Social Determinants
Verified date | March 2018 |
Source | University Hospital, Lille |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Elderly cancer patients need more help from their relatives and for longer than young adults.
Our hypothesis of research is that the needs and resources to help the couple " elderly
patient/caregiver ", are at least in part socially determined and that the implementation of
a personalized support plan to help the caregiver (PSP) taking into account needs, resources
and expectations of the primary caregiver in addition to those of elderly patients with
cancer may partly correct inequalities. The PSP should allow a better management of cancer, a
lesser burden for the caregiver and a better quality of life for both the caregiver and the
patient.
Status | Terminated |
Enrollment | 78 |
Est. completion date | December 1, 2017 |
Est. primary completion date | June 12, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Identification of a patient / caregiver couple - Be the primary caregiver for at least one month of a subject - Age =70 years - With cancer - Who benefited a comprehensive geriatric assessement at University Lille Hospital or Centre Oscar Lambret - Affiliated to a social security or receiving an equivalent system of social protection - caregiver able to understand the nature, purpose and methodology of the study - caregiver able to cooperate in interviews and questionnaires - Written informed consent of the caregiver and the cancer patient provided before any study specific procedures Exclusion Criteria: - Caregiver < 18 years old - Legal inability or restricted legal ability - Inability to attend or comply with interventions or follow-up scheduling, disability or difficulty preventing a proper understanding of trial instructions - patient's life expectancy less than 6 months (clinical assessment) |
Country | Name | City | State |
---|---|---|---|
France | Centre Oscar Lambret | Lille | |
France | University hospital, Lille | Lille |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Lille | Centre Oscar Lambret, National Cancer Institute, France, University of Lille Nord de France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Relationship between needs and EPICES score | baseline | ||
Primary | change in caregiver burden (22 items Zarit Burden Interview) | 6 months | ||
Secondary | Link between caregiver burden (ZBI) and the indicator of precariousness (EPICES score) | baseline evaluation | ||
Secondary | psychosocial characteristics of caregivers of patients with cancer | Caregiver Reaction Assessment (CRA) Carers' Assessment of Managing Index (CAMI) Inventory of social support (ISSB) Hospital Anxiety and Depression Scale (HADS) Cognitive Inventory of Subjective Distress (CISD) Subjective well-being scale (BES) | baseline and 6 months | |
Secondary | Link between caregiver burden and geriatric syndromes | baseline and 6 months | ||
Secondary | Link between caregiver burden and stage of cancer / time from cancer diagnosis | baseline | ||
Secondary | Match between caregiver personalized support plan (PSP) objectives and effective implemented PSP | 6 months | ||
Secondary | Time spent for the development and implementation of the caregiver personalized support plan | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04848376 -
Post-Market Clinical Follow-up Study of A-SPINE's Products
|
||
Active, not recruiting |
NCT05470283 -
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
|
Phase 1 | |
Completed |
NCT05041920 -
A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects
|
Phase 1 | |
Recruiting |
NCT04430361 -
the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
|
Phase 2 | |
Not yet recruiting |
NCT05549557 -
IMM40H Phase I Dose Escalation and Expansion
|
Phase 1 | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 | |
Terminated |
NCT01846429 -
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
|
Phase 1 | |
Completed |
NCT01946555 -
Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
|
N/A | |
Recruiting |
NCT01387971 -
Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders
|
N/A | |
Recruiting |
NCT01093079 -
Laparoscopic Versus Open Partial Nephrectomy - Surgical and Oncological Outcomes
|
N/A | |
Recruiting |
NCT00690261 -
The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction
|
N/A | |
Completed |
NCT00561795 -
Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors
|
Phase 2 | |
Completed |
NCT00413322 -
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT00152659 -
Developing Criteria for Cortical Resections
|
||
Completed |
NCT00777751 -
Radiation Therapy and Cardiac Enzymes
|
N/A | |
Not yet recruiting |
NCT06109896 -
Clinical Stories and Psychological Experiences of Cancer Patients
|
||
Not yet recruiting |
NCT05879146 -
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
|
Phase 2 | |
Recruiting |
NCT02810405 -
Collection of Tissue Blocks or Slides From Patients With Cancer
|
||
Recruiting |
NCT01867268 -
Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence
|
Phase 2 | |
Completed |
NCT01919710 -
Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia
|
Phase 1 |